Modelling Human Brucellosis Based on Infection Rate and Vaccination Coverage of Sheep and Goats

In this study, the vaccination coverage, serological sampling and infection rate of sheep and goats were evaluated as predictors for the modeling of human brucellosis in Greece. The human brucellosis disease frequency per local regional unit (RU) varied significantly (RR90) among consecutive years....

Full description

Saved in:
Bibliographic Details
Published inPathogens (Basel) Vol. 11; no. 2; p. 167
Main Authors Dougas, Georgios, Katsiolis, Aristomenis, Linou, Maria, Kostoulas, Polychronis, Billinis, Charalambos
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 27.01.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this study, the vaccination coverage, serological sampling and infection rate of sheep and goats were evaluated as predictors for the modeling of human brucellosis in Greece. The human brucellosis disease frequency per local regional unit (RU) varied significantly (RR90) among consecutive years. The notification rate was higher ( < 0.001) in the RUs with implementation of vaccination in sheep and goats (vaccination zone-VZ) with a median of 1.4 (IQR 0.0-3.1) compared with the RUs of the eradication zone (EZ) with a median of 0.0 (IQR 0.0-0.0). In VZ, the increased frequency of human cases was associated with delayed vaccine administration (estimate: 0.14 (0.04; 0.29), = 0.03) and higher vaccination coverage of the animals (estimate: -0.349 (-0.72; -0.07), < 0.01). However, the flock sampling rate was highly heterogenous among RUs (IQR 10.56-52.93), and inconsistent within RUs throughout the period of the study 2013-2017 ( = 0.001), limiting the reliable estimation of the infection rate in livestock and the design of an integrated One Health model for human disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:2076-0817
2076-0817
DOI:10.3390/pathogens11020167